Potential cardiovascular benefits of canagliflozin compared with other diabetes drugs
Intended for healthcare professionals
Journal scan Previous     Next

Potential cardiovascular benefits of canagliflozin compared with other diabetes drugs

Ruth Sander Independent consultant, Care of the older person

Medications for type 2 diabetes have different modes of action. The various non-gliflozin drugs work by stimulating production of insulin, reducing glucagon which increases blood sugar levels or enhancing the action of insulin in the body.

Nursing Older People. 30, 3, 11-11. doi: 10.7748/nop.30.3.11.s8

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more